Schedule 13D ownership disclosure

ARGOS THERAPEUTICS INC

Security class unavailable · CUSIP: 040221103

Event date: 2018-01-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.9300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-039807
Form type
SC 13D/A
Filer
ARGOS THERAPEUTICS INC
CIK
CIK 1105533
Filed
Feb 14, 2019
Reporting period
Jan 18, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub

SC 13D/A | SEC Filings Hub